RecommendationWhat are your top 3 buys right now if you were investing in a mix of growth, quality, and somewhat reasonable valuation? With your answer/explanation can you include fwd p/e or whatever relevant metrics vs peers? For three names that we feel have a good mix of growth, quality, and a decent valuation, we like: BN (21.6X forward earnings, 10.7% 10-year CAGR), EQB (7.7X forward earnings, 13.9% 10-year CAGR), and ATD (18.9X forward earnings,19.2% 10-year CAGR). (5iResearch)